Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia. Belleville S, et al, Alzheimers Dement 2022.
Notes sur les tags :
Réaliser des modifications :
Pour modifier ce document, il est nécessaire d'être connecté au site. Pour cela, assurez-vous d'avoir des identifiants valides. Si vous n'en avez pas,
contactez-nous. Pour vous connecter, cliquez sur l'icône
dans la barre de navigation.
Résumé et points clés
Background: Little is known regarding the dose-response function in multidomain interventions for dementia prevention.
Method: The Multidomain Alzheimer Preventive Trial is a 3-year randomized controlled trial comprising cognitive training, physical activity, nutrition, and omega-3 polyunsaturated fatty acids for at-risk older adults. The dose delivered (number of sessions attended) was modeled against global cognition, memory, and fluency in 749 participants. Interaction effects were assessed for age, sex, education, dementia score (CAIDE), frailty score, and apolipoprotein E (APOE) ε4 status.
Results: The dose-response models were non-linear functions indicating benefits up to about 12 to 14 training hours or 15 to 20 multidomain sessions followed by a plateau. Participants who benefited from a higher dose included women, younger participants, frail individuals, and those with lower education or lower risk of dementia.
Discussion: The non-linear function indicates that a higher dose is not necessarily better in multidomain interventions. The optimal dose was about half of the potentially available sessions.
Références de l'article
- Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia.
- Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia.
- Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T, MAPT/DSA group
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- 2022
- Alzheimers Dement. 2022 Nov;18(11):2140-2150. doi: 10.1002/alz.12544. Epub 2022 Jan 20.
- Aged, Female, Humans, *Alzheimer Disease/prevention & control, Apolipoprotein E4/genetics, Cognition, *Cognition Disorders, Exercise, *Fatty Acids, Omega-3, Male
- Syndromes_Geriatriques, Neurocognitif, Neurocognitif
- Liens
- Traduction automatique en Français sur Google Translate
- DOI: 10.1002/alz.12544
- PMID: 35049127
- Articles similaires
- Cité par
- Références
- Texte complet gratuit
- Twitter
- Twitter cet article (lien vers l'article)
- Twitter cet article (lien vers cette page)
Éditer la discussion
Références